These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17512574)

  • 21. Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism.
    Rumbaut RE; Bellera RV; Randhawa JK; Shrimpton CN; Dasgupta SK; Dong JF; Burns AR
    Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1671-9. PubMed ID: 16284241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases.
    Kram L; Grambow E; Mueller-Graf F; Sorg H; Vollmar B
    Thromb Res; 2013 Aug; 132(2):e112-7. PubMed ID: 23916820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo analysis of antithrombotic effectiveness of recombinant hirudin on microvascular thrombus formation and recanalization.
    Roesken F; Vollmar B; Rücker M; Seiffge D; Menger MD
    J Vasc Surg; 1998 Sep; 28(3):498-505. PubMed ID: 9737460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model.
    Lynch JJ; Sitko GR; Lehman ED; Vlasuk GP
    Thromb Haemost; 1995 Aug; 74(2):640-5. PubMed ID: 8585000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin.
    Rumbaut RE; Randhawa JK; Smith CW; Burns AR
    Microcirculation; 2004; 11(3):239-47. PubMed ID: 15280078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
    Hoffmann JN; Wiedermann CJ; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Warren BL; Opal SM;
    Thromb Haemost; 2006 May; 95(5):850-6. PubMed ID: 16676077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
    Malm K; Dahlbäck B; Arnljots B
    Plast Reconstr Surg; 2003 Apr; 111(5):1659-66. PubMed ID: 12655212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
    Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
    J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
    Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent effect of clonidine on microvascular permeability during endotoxemia.
    Schmidt K; Hernekamp JF; Philipsenburg C; Zivkovic AR; Brenner T; Hofer S
    Microvasc Res; 2015 Sep; 101():111-7. PubMed ID: 26177515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat.
    Emerson TE; Fournel MA; Leach WJ; Redens TB
    Circ Shock; 1987; 21(1):1-13. PubMed ID: 3545529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of in vivo function of CD31 in vascular thrombosis.
    Vollmar B; Schmits R; Kunz D; Menger MD
    Thromb Haemost; 2001 Jan; 85(1):160-4. PubMed ID: 11204568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.
    Santos JC; Mesquita JM; Belmiro CL; da Silveira CB; Viskov C; Mourier PA; Pavão MS
    Thromb Res; 2007; 121(2):213-23. PubMed ID: 17482241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel antithrombin-heparin covalent complex: antithrombotic and bleeding studies in rabbits.
    Chan AK; Berry L; Klement P; Julian J; Mitchell L; Weitz J; Hirsh J; Andrew M
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):587-95. PubMed ID: 9863706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin mediates the extraintestinal thrombosis associated with experimental colitis.
    Yoshida H; Russell J; Granger DN
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G904-8. PubMed ID: 18772359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the factor Xa inhibitor rivaroxaban on arterial thrombosis in wild-type and apolipoprotein E-deficient mice.
    Wagner NM; Dressel T; Schäfer K; Konstantinides S
    Thromb Res; 2012 Nov; 130(5):793-8. PubMed ID: 22281071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses.
    Olsson E; Asko-Seljavaara S; Lassila R
    Thromb Haemost; 2002 Feb; 87(2):245-51. PubMed ID: 11858484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.